Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
by Karthikeyan Subramani
International Journal of Nanotechnology (IJNT), Vol. 3, No. 4, 2006

Abstract: This paper discusses potential applications of nanotechnology in drug delivery systems and pharmacotherapeutics. There are a few limitations in the use of conventionally available drug delivery systems as pharmacological agents in disease treatment. Lack of target specificity, altered effects and diminished potency due to drug metabolism in the body, cytotoxicity of certain anti-carcinogenic pharmacological agents, are to mention a few. Biocompatible nanoparticles with optimised physical, chemical and biological properties can serve as effective drug delivery systems. These newer generations of drug delivery systems have significant advantages over the conventionally available drug delivery systems. This article discusses the need for nanotechnology-based drug delivery systems, their advantages, applications and limitations of such drug delivery systems in the treatment of cancer and diabetes.

Online publication date: Fri, 20-Oct-2006

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com